Patience, yes, for those long on RVX.

We have trusted science over management.  Congrats to the real believers.  Appears a pandemic may have saved RVX while many died only to save a mismanaged business.  Been a long time from hearing Histone H2, APO A-1, and usable HDL.  As the song went "where have all the flowers gone" (may not be the write words but the song still lives).  Flowers have turned to years.

Question to our scientist and those knowledgeable in the pharma industry. 

With an open study what is the duration between announcements? 

Will we be informed at the release or death of our first patient? 

Will we be informed, at least weekly, the newly enrolled patients?

Reviewing the study dates, shows later this year two release dates on results.  One is September and the other in October (or very close).  How does this compare with an "open study" announcement?

May the first patient have a very long, wonderful life!

I imagine those shorting RVX may begin high blood pressure treatment.  Seems nearly impossible to short a price in the pennies.  Yet, there they are.  Current volume will be those covering their shorts.  Next volume, those wanting to jump, get in early with few dollars invested.  Next will be the true investors.  Watch out for big pharma in next two years (if successful), hoping for large offer.  LARGE.  

Will be interesting if P2b is successful.  From 40 to 55 cents only way is up.  At this price down does not matter.  Not much more to lose.  sidebar.  And still very long – 2009 or near there.

Thank you to all who take time to read, provide insights and wisdom. Good health to you today and all of your tomorrows.